4//SEC Filing
DESOUZA ERROL B 4
Accession 0000950170-23-067736
CIK 0001755237other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:05 PM ET
Size
6.5 KB
Accession
0000950170-23-067736
Insider Transaction Report
Form 4
DESOUZA ERROL B
Director
Transactions
- Award
Common Stock
2023-11-30+30,000→ 30,000 total - Award
Common Stock
2023-11-30+20,000→ 50,000 total
Footnotes (2)
- [F1]The Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 2,500 of these shares vest immediately and the remaining 17,500 shares vest ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
- [F2]The Reporting Person was granted 30,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 3,750 of these shares vest immediately and the remaining 26,250 shares vest ratably over a 42-month period, provided that the Reporting Person remains as Chair of the Board of Directors of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
Documents
Issuer
Cyclerion Therapeutics, Inc.
CIK 0001755237
Entity typeother
Related Parties
1- filerCIK 0001213895
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:05 PM ET
- Size
- 6.5 KB